Premium
Effect of lifestyle factors and hormone therapy on heart function by serial echocardiography in postmenopausal women
Author(s) -
KHOO SooKeat,
O’NEILL Sheila,
SCALIA Gregory,
TRIPCONY Lee
Publication year - 2010
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/j.1479-828x.2009.01112.x
Subject(s) - medicine , ejection fraction , hormone therapy , hazard ratio , adverse effect , cardiology , confidence interval , hormone , population , hormone replacement therapy (female to male) , endocrinology , heart failure , breast cancer , cancer , environmental health , testosterone (patch)
Background: There is conflicting information on the effects of oestrogen on the heart in women, especially those using postmenopausal hormone therapy. Whilst some studies reported a beneficial effect, others showed adverse outcomes. The interplay of lifestyle factors and type/timing of therapy remains to be clarified. Aim: The aim of this study was to determine the effects of lifestyle and hormone therapy on heart function and structure in postmenopausal women. Method: As part of a large longitudinal study of women randomly recruited from an urban population, the study assessed 410 suitable women by echocardiography in Year 1 and Year 5 of the study by two independent cardiologists. Results: In lifestyle characteristics, the difference in age and body mass (as markers of cardiovascular risk) was in favour of never‐users versus hormone therapy‐users. Using an arbitrary cut‐off ≥15% change for an effect, we found lifestyle factors had minimal effect on the two measured parameters – ejection fraction, left ventricular mass. Effects of hormone therapy were variable and mixed; greatest effect was found for an ‘early start’ of hormone therapy with oestrogen‐only preparation – the risk of reduced ejection fraction was decreased [hazard ratio (HR) 0.42, confidence interval = 0.17–1.03, P = 0.06] and risk of increased left ventricular mass was increased (HR 2.21, 1.09–4.49, P = 0.03). Conclusion: Our findings add to the evidence that oestrogen given to postmenopausal women has a mixed effect on the heart, with effect best shown when started early.